article June 12, 2021
FDA leader discusses breaking barriers in clinical research
Javara CEO Jennifer Byrne kicked off this series by sharing the history of CRAACO and ways to bring clinical research closer to clinical care. In the next article, Acting FDA Commissioner Janet Woodcock discusses possible pathways to improving the infrastructure, including the creation of community networks and forging relationships with local care providers to offer clinical research as a care option. Two leaders, one vision. Click the link below to read the full article:
Javara is the leading Integrated Research Organization (IRO) partnering with large healthcare organizations in local communities across the US to integrate clinical research into clinical care. Our access to broad diverse patient populations through their trusted physicians ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. Our team includes experienced clinical research leaders who have collectively led 10,000+ trials and engaged 200,000+ patients in clinical trials. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, please visit Javararesearch.com.
Javara Media Contact: